Z Squared, Coeptis Merge to Form Largest Public Dogecoin Miner

Z Squared, a firm specializing in mining Dogecoin (DOGE), has announced a merger with Coeptis, a biopharmaceutical company. This strategic move aims to create one of the largest publicly-traded companies focused on mining Dogecoin and other cryptocurrencies like Litecoin (LTC). The merger will allow the resulting company to continue its DOGE mining operations while spinning out Coeptis’ pharmaceutical business to operate separately.

David Halabu, CEO of Z Squared, highlighted the benefits of going public, stating that it provides broader access to capital markets. This access will fuel the growth of mining operations and pursue additional strategic opportunities that are expected to be beneficial for shareholders. The transaction is anticipated to close in the third quarter of 2025, with the combined entity possessing 9,000 U.S.-based DOGE mining machines.

Dogecoin, which was spun off from Bitcoin (BTC) in 2013, follows a similar Proof-of-Work consensus mechanism. This means miners compete to solve an algorithmic problem to produce the next block on the blockchain, with the first solver being rewarded with coins. Currently, DOGE has a market capitalization of $27 billion, making it the eighth-largest cryptocurrency, just ahead of Cardano’s ADA and Tron’s TRX.

With the increasing competitiveness in the Bitcoin mining industry, mining operations are exploring new revenue streams. For instance, some firms are dedicating resources to AI purposes or mining other cryptocurrencies like Dogecoin and Litecoin. This trend is evident as companies seek to diversify their revenue sources and capitalize on the growing interest in alternative cryptocurrencies.

Coeptis Therapeutics has announced a definitive merger agreement with Z Squared, aiming to create the largest publicly-traded, Dogecoin-focused mining company. The merger involves Coeptis acquiring Z Squared's 9,000 Dogecoin mining rigs through an equity swap. This acquisition positions Coeptis as a leading public Dogecoin mining company, although specific details regarding operational economics and profitability have not been disclosed.

The combined entity will focus on advancing Z Squared's expertise in digital asset mining, with a primary emphasis on generating Dogecoin. The merger is subject to customary closing conditions, including regulatory approvals and shareholder consent. The Boards of Directors of both companies have approved the proposed merger, signaling a strategic shift for Coeptis away from its biotech roots and towards the cryptocurrency mining sector.

The merger is expected to significantly enhance Coeptis' capabilities in the digital asset mining space, leveraging Z Squared's established infrastructure and expertise. This move aligns with the growing interest in cryptocurrency mining, particularly for Dogecoin, which has seen increased attention and adoption in recent years. The acquisition of 9,000 mining rigs will provide the combined company with a substantial mining capacity, positioning it as a major player in the Dogecoin mining landscape.

The merger represents a pivotal moment for Coeptis, as it transitions from a biotech company to a cryptocurrency mining firm. This strategic pivot is likely driven by the potential for higher returns and growth in the digital asset mining sector compared to the biotech industry. However, the success of this transition will depend on various factors, including the operational efficiency of the mining rigs, the stability of the Dogecoin market, and the company's ability to manage the complexities of cryptocurrency mining operations.

The merger agreement includes a rebranding of Coeptis to Z Squared, reflecting the company's new focus on digital asset mining. This rebranding is a clear indication of the company's commitment to its new direction and its intention to establish itself as a leader in the Dogecoin mining industry. The merger is expected to close in the near future, subject to the satisfaction of the customary closing conditions.